PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
 
Proc R Soc Med. 1961 May; 54(5): 423–426.
PMCID: PMC1869540

Sulphinpyrazone in the Treatment of Arthritis associated with Hyperuricæmia

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (745K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • BURNS JJ, YU TF, RITTERBAND A, PEREL JM, GUTMAN AB, BRODIE BB. A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue, G-25671. J Pharmacol Exp Ther. 1957 Mar;119(3):418–426. [PubMed]
  • KERSLEY GD, COOK ER, TOVEY DC. Value of uricosuric agents and in particular of G. 28 315 in gout. Ann Rheum Dis. 1958 Sep;17(3):326–333. [PMC free article] [PubMed]
  • LANSBURY J, HAUT DD. Quantitation of the manifestations of rheumatoid arthritis. 4. Area of joint surfaces as an index to total joint inflammation and deformity. Am J Med Sci. 1956 Aug;232(2):150–155. [PubMed]
  • OGRYZLO MA, HARRISON J. Evaluation of uricosuric agents in chronic gout. Ann Rheum Dis. 1957 Dec;16(4):425–437. [PMC free article] [PubMed]
  • SEEGMILLER JE, GRAYZEL AI. Use of the newer uricosuric agents in the management of gout. JAMA. 1960 Jul 9;173:1076–1080. [PubMed]
  • YU TF, BURNS JJ, GUTMAN AB. Results of a clinical trial of G-28315, a sulfoxide analog of phenylbutazone, as a uricosuric agent in gouty subjects. Arthritis Rheum. 1958 Dec;1(6):532–543. [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press